4//SEC Filing
Crombez Eric 4
Accession 0001209191-23-026692
CIK 0001515673other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 6:18 PM ET
Size
7.7 KB
Accession
0001209191-23-026692
Insider Transaction Report
Form 4
Crombez Eric
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2023-05-01+4,658→ 30,512 total - Award
Stock Option (Right to Buy)
2023-05-01+8,362→ 8,362 totalExercise: $44.03Exp: 2033-05-01→ Common Stock (8,362 underlying)
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]The option shall vest with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares initially subject to the option shall continue to vest on each month such that the option will fully vest on the fourth anniversary of the grant date.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001653052
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 6:18 PM ET
- Size
- 7.7 KB